Skip to main content

Day: September 27, 2024

Equasens: 2024 half-year results

Villers-lès-Nancy, 27 September 2024 – 6:00 p.m. (CET) PRESS RELEASE 2024 half-year resultsGroup results impacted by weaker economic conditions and continuing investment efforts in H1:Revenue: €108.0m, -4.1% Current Operating Income: €20.9m, -24.1%Net Profit attributable to the Group: €17.2m, -21.8%Though with a profit margin that continues to be very positive:Ratio of Current Operating Income (COI) to Sales: 19.3% on a reported basis and 20.0% like-for-likeH1 RESULTS (€M) 2023reported basis 2024reported basis Change / Reported basis External growth Change / Like-for-like basisRevenue 112.6 108.0 -4.6 -4.1% -3.7 -8.3 -7.4%Current operating income (COI) 27.5 20.9 -6.6 -24.1% 0.0 -6.7 -24.3%Net Profit 22.9 18.1 -4.8 -21.0% 0.0 -4.8 -21.1%Net Profit attributable to the Group 22.0 17.2 -4.8 -21.8%      The...

Continue reading

Cargotec Corporation: Share Repurchase 27.9.2024

CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 27 SEPTEMBER 2024 AT 6.30 PM (EET)          CARGOTEC CORPORATION: SHARE REPURCHASE 27.9.2024       In the Helsinki Stock Exchange         Trade date           27.9.2024  Bourse trade         Buy  Share                  CGCBV  Amount             6 500 SharesAverage price/ share    53,1330 EURTotal cost            345 364,50 EUR          Cargotec Corporation now holds a total of 784 050 sharesincluding the shares repurchased on 27.9.2024            On behalf of Cargotec Corporation         Nordea Bank Oyj         Janne Sarvikivi           Sami Huttunen                 For further information, please contact: Aki Vesikallio, Vice President, Investor Relations, tel. +358 40 729 1670 Cargotec’s (Nasdaq Helsinki:...

Continue reading

Reykjavík Energy | €75 million financing for strengthening utility systems

The Council of Europe Development Bank (CEB) has approved a €75 million loan to Reykjavík Energy to expand utility systems and enhance their resilience against climate threats and natural disasters. The funding, equivalent to over ISK 11 billion, will be used for the development of electricity, heating, and water utilities. A significant increase in population in Iceland‘s capital area has demanded development of new housing which is connected to Orkuveitan’s subsidiary Veitur Utilities‘ systems. Alongside the expansion of the utilities, efforts are being made to secure additional geothermal resources for the district heating system and investments are needed in the electric grid to meet energy transitions. All utilities‘ need to be strengthened due to the impacts of climate change such as rising sea levels, increased precipitation...

Continue reading

Results for the Period Ended 30 June 2024

Octopus Future Generations VCT plc Results for the Period Ended 30 June 2024 Octopus Future Generations VCT plc (‘Future Generations VCT’ or the ‘Company’) is backing businesses that aim to address society’s biggest challenges, providing an opportunity for investors to share in the growth of ambitious, purpose‑driven companies. The Company is managed by Octopus AIF Management Limited (the ‘Manager’), who has delegated investment management to Octopus Investments Limited (‘Octopus’ or ‘Portfolio Manager’) via its investment team Octopus Ventures. The Company today announces the unaudited financial report for the twelve months ended 30 June 2024. Chair’s statement Highlights£46.1m in total net assets 86.8p Net Asset Value (NAV) per share 36 portfolio companies I am pleased to present the unaudited financial report and accounts for...

Continue reading

Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions

SOUTH SAN FRANCISCO, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional data from SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of Obstruction Impact of Aficamten in HCM), the pivotal Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), were presented at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions by Anjali T. Owens, M.D., Medical Director of the Center for Inherited Cardiac Disease and Assistant Professor of Medicine at the University of Pennsylvania. A new analysis from SEQUOIA-HCM showed that treatment with aficamten was associated with beneficial changes in five indices reflecting structural, electrophysiologic and biomarker changes in patients from SEQUOIA-HCM....

Continue reading

WTW expands Asia Client Division – CRB N.A. with new China Client Division Leader for North America

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the launch of a new China Client Division within Corporate Risk and Broking, North America (CRB NA), marking a significant milestone in the company’s strategy to expand its presence and broaden offerings focused on the Chinese market. The new China Client Division is part of the broader Asia Risk Division, established in December 2023, which encompasses country-specific teams for Japan, South Korea, India, and China. These particular groups were created to address the specific cultural and economic dynamics of each country, alongside their distinctive approaches to risk management in each market. All practice groups within the Asia Risk Division report to Chris Condello, Head of the Asia Risk...

Continue reading

Horizon Bancorp, Inc. Announces Conference Call to Review Third Quarter 2024 Results on October 24

MICHIGAN CITY, Ind., Sept. 27, 2024 (GLOBE NEWSWIRE) — (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”) will host a conference call at 7:30 a.m. CT on Thursday, October 24, 2024 to review its third quarter 2024 financial results. The Company’s third quarter news release will be published after markets close on Wednesday, October 23, 2024. It will be available at investor.horizonbank.com. Participants may access the live conference call on October 24, 2024 at 7:30 a.m. CT (8:30 a.m. ET) by dialing 833-974-2379 from the United States, 866-450-4696 from Canada, or 412-317-5772 from international locations and requesting the “Horizon Bancorp Call.” Please dial in approximately 10 minutes prior to the call. A telephone replay of the call will be available approximately one hour after the end of the conference call...

Continue reading

Kronos Advanced Technologies Inc. and Yasheng Group Announce Key Milestone in Nuclear Battery Collaboration with Provisional Patent Filing

Parkersburg, WV, Sept. 27, 2024 (GLOBE NEWSWIRE) — Kronos Advanced Technologies Inc. (OTC: KNOS) and Yasheng Group (OTC: HERB) are proud to announce significant progress in their ongoing collaboration to develop a revolutionary small nuclear-powered battery. On Thursday, September 26, 2024, the companies jointly filed a provisional patent with the United States Patent and Trademark Office (USPTO), marking a pivotal step toward commercializing this groundbreaking technology. The nuclear battery, may have potential to provide reliable power in milliwatts for up to 50 years without requiring recharging, is intended to address critical energy needs across multiple industries, including remote sensing, space exploration, medical devices, and military applications. The filing of this provisional patent underscores the technological advancement...

Continue reading

Oil-Dri Named One of the Top 100 Finalists for the 23rd Annual Chicago Innovation Awards

CHICAGO, Sept. 27, 2024 (GLOBE NEWSWIRE) — Out of 350 nominees, Oil-Dri Corporation of America (NYSE: ODC), headquartered in Chicago, has been selected as one of the Top 100 Finalists in the running for the 23rd annual Chicago Innovation Awards. The awards celebrate the most innovative new products and services in the Chicago region across all organization sizes, sectors and industries. Over 700 business and civic leaders will come together to honor the winners when they are announced on November 14, 2024 at the UIC Forum. Oil-Dri was nominated for the development of its Cat’s Pride® Antibacterial Clumping Litter which is the first and only EPA-approved cat litter to kill 99.9% of odor-causing bacteria. Antibacterial cat litter was a concept that was tested and found to be highly relevant to conscientious cat owners who seek a...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.